Aayush Wellness Share Price
Sector: Biotechnology & Drugs
198.95 +3.90 (2.00%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
198.95
Today’s High
198.95
52 Week Low
16.80
52 Week High
195.05
Key Metrics
- Market Cap (In Cr) 968.32
- Beta -0.01
- Div. Yield (%) 0.01
- P/B 116.93
- TTM P/E 81.81
- Sector P/E 0
- D/E 0
- Open Price 198.95
- Prev Close 195.05
Aayush Wellness Analysis
Price Analysis
-
1 Week10.37%
-
3 Months254.63%
-
6 Month52.92%
-
YTD59.22%
-
1 Year909.9%
Risk Meter
- 47% Low risk
- 47% Moderate risk
- 47% Balanced Risk
- 47% High risk
- 47% Extreme risk
Aayush Wellness News
Multibagger small-cap stock hits upper circuit despite sell-off in stock market
1 min read . 23 Jun 2025Multibagger small-cap stock hits record high; gives 4000% returns in 5 years
2 min read . 18 Jun 2025Small-cap stock below ₹200 hits upper circuit after THIS business update
1 min read . 10 Jun 20255600% rally in 2 years! This multibagger hits upper circuit in all May sessions
2 min read . 19 May 2025Aayush Wellness Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 73.35
- Selling/ General/ Admin Expenses Total
- 0
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.98
- Total Operating Expense
- 69.91
- Operating Income
- 3.43
- Net Income Before Taxes
- 3.37
- Net Income
- 3.37
- Diluted Normalized EPS
- 0.69
- Period
- 2025
- Total Assets
- 8.65
- Total Liabilities
- 0.37
- Total Equity
- 8.28
- Tangible Book Valueper Share Common Eq
- 1.7
- Period
- 2025
- Cashfrom Operating Activities
- 0.49
- Cashfrom Investing Activities
- -0.11
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0.38
- Period
- 2024
- Total Revenue
- 0.6
- Selling/ General/ Admin Expenses Total
- 0.11
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.14
- Total Operating Expense
- 0.25
- Operating Income
- 0.36
- Net Income Before Taxes
- 0.59
- Net Income
- 0.57
- Diluted Normalized EPS
- 0.12
- Period
- 2024
- Total Assets
- 5.02
- Total Liabilities
- 0.1
- Total Equity
- 4.92
- Tangible Book Valueper Share Common Eq
- 1.01
- Period
- 2024
- Cashfrom Operating Activities
- -0.57
- Cashfrom Investing Activities
- 0
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.57
- Period
- 2023
- Total Revenue
- 8.1
- Selling/ General/ Admin Expenses Total
- 0.04
- Depreciation/ Amortization
- 0.03
- Other Operating Expenses Total
- 0.96
- Total Operating Expense
- 8.63
- Operating Income
- -0.53
- Net Income Before Taxes
- -0.35
- Net Income
- -0.34
- Diluted Normalized EPS
- -0.08
- Period
- 2023
- Total Assets
- 4.48
- Total Liabilities
- 0.08
- Total Equity
- 4.41
- Tangible Book Valueper Share Common Eq
- 0.91
- Period
- 2023
- Cashfrom Operating Activities
- 4.62
- Cashfrom Investing Activities
- 0.18
- Cashfrom Financing Activities
- -4.95
- Net Changein Cash
- -0.15
- Period
- 2022
- Total Revenue
- 17.46
- Selling/ General/ Admin Expenses Total
- 0.49
- Depreciation/ Amortization
- 0.07
- Other Operating Expenses Total
- 1.87
- Total Operating Expense
- 19.44
- Operating Income
- -1.98
- Net Income Before Taxes
- -2.1
- Net Income
- -2.08
- Diluted Normalized EPS
- -0.48
- Period
- 2022
- Total Assets
- 11.14
- Total Liabilities
- 6.39
- Total Equity
- 4.75
- Tangible Book Valueper Share Common Eq
- 0.98
- Period
- 2022
- Cashfrom Operating Activities
- -2.69
- Cashfrom Investing Activities
- 0.44
- Cashfrom Financing Activities
- 2.75
- Net Changein Cash
- 0.5
- Period
- 2021
- Total Revenue
- 151.6
- Selling/ General/ Admin Expenses Total
- 0.72
- Depreciation/ Amortization
- 0.14
- Other Operating Expenses Total
- 15.53
- Total Operating Expense
- 149.68
- Operating Income
- 1.92
- Net Income Before Taxes
- 0.59
- Net Income
- 0.42
- Diluted Normalized EPS
- 0.09
- Period
- 2021
- Total Assets
- 36.33
- Total Liabilities
- 29.52
- Total Equity
- 6.8
- Tangible Book Valueper Share Common Eq
- 1.4
- Period
- 2021
- Cashfrom Operating Activities
- 6.46
- Cashfrom Investing Activities
- -0.01
- Cashfrom Financing Activities
- -9.33
- Net Changein Cash
- -2.88
- Period
- 2020
- Total Revenue
- 127.38
- Selling/ General/ Admin Expenses Total
- 0.81
- Depreciation/ Amortization
- 0.1
- Other Operating Expenses Total
- 9.81
- Total Operating Expense
- 125.66
- Operating Income
- 1.73
- Net Income Before Taxes
- 0.85
- Net Income
- 0.62
- Diluted Normalized EPS
- 0.13
- Period
- 2020
- Total Assets
- 46.45
- Total Liabilities
- 40.07
- Total Equity
- 6.38
- Tangible Book Valueper Share Common Eq
- 1.31
- Period
- 2020
- Cashfrom Operating Activities
- -9.94
- Cashfrom Investing Activities
- -0.21
- Cashfrom Financing Activities
- 10.69
- Net Changein Cash
- 0.54
- Period
- 2019
- Total Revenue
- 131.68
- Selling/ General/ Admin Expenses Total
- 1.25
- Depreciation/ Amortization
- 0.1
- Other Operating Expenses Total
- 6.91
- Total Operating Expense
- 131.89
- Operating Income
- -0.21
- Net Income Before Taxes
- 0.82
- Net Income
- 0.6
- Diluted Normalized EPS
- 0.12
- Period
- 2019
- Total Assets
- 35.29
- Total Liabilities
- 29.53
- Total Equity
- 5.76
- Tangible Book Valueper Share Common Eq
- 1.18
- Period
- 2019
- Cashfrom Operating Activities
- -2.69
- Cashfrom Investing Activities
- -0.03
- Cashfrom Financing Activities
- 0.78
- Net Changein Cash
- -1.95
- Period
- 2025-03-31
- Period
- 2025-03-31
- Total Assets
- 8.65
- Total Liabilities
- 0.37
- Total Equity
- 8.28
- Tangible Book Valueper Share Common Eq
- 1.7
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 0.49
- Cashfrom Investing Activities
- -0.11
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0.38
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Period
- 2024-09-30
- Total Assets
- 6.1
- Total Liabilities
- 0.01
- Total Equity
- 6.09
- Tangible Book Valueper Share Common Eq
- 1.25
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 1.43
- Cashfrom Investing Activities
- -0.01
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 1.42
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Period
- 2024-03-31
- Total Assets
- 5.02
- Total Liabilities
- 0.1
- Total Equity
- 4.92
- Tangible Book Valueper Share Common Eq
- 1.01
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -0.57
- Cashfrom Investing Activities
- 0
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.57
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Aayush Wellness Technical
Moving Average
SMA
- 5 Day187.58
- 10 Day178.8
- 20 Day162.85
- 50 Day125.27
- 100 Day93.08
- 300 Day85.84
Aayush Wellness Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Kwality Pharmaceuticals
- 1014.55
- -10.35
- -1.01
- 1140
- 481
- 1054.68
- Anuh Pharma
- 212.1
- 4.05
- 1.95
- 249.95
- 148.05
- 1062.88
- Aayush Wellness
- 198.95
- 3.9
- 2
- 195.05
- 16.8
- 968.32
- Fermenta Biotech
- 323.55
- 6.3
- 1.99
- 449
- 163
- 952.24
- Wanbury
- 285.2
- 9.8
- 3.56
- 330
- 151.1
- 935.97
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Kwality Pharmaceuticals
- 26.72
- 4.03
- 26.54
- 13.21
- Anuh Pharma
- 21.88
- 3.18
- 17.15
- 7.35
- Aayush Wellness
- 282.68
- 114.64
- 6.88
- 0.77
- Fermenta Biotech
- 12.04
- 2.55
- 3.78
- 2.92
- Wanbury
- 30.36
- 15.07
- -
- 5.62
Aayush Wellness Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 30-May-25
- Audited Results
- 29-May-25
- Audited Results
- 25-Feb-25
- Interim Dividend & Others
- 13-Feb-25
- Quarterly Results
- 13-Nov-24
- Quarterly Results
- 29-Oct-24
- Bonus issue
- 12-Aug-24
- Quarterly Results
- 19-Jun-24
- Stock Split & ESOP
- 27-May-24
- Audited Results
- 28-Mar-24
- Others
- Meeting Date
- Announced on
- Purpose
- 03-Dec-24
- 29-Oct-24
- POM
- 27-Sept-24
- 11-Sept-24
- AGM
- 25-Jul-24
- 21-Jun-24
- POM
- 30-Sept-23
- 06-Sept-23
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 25-Feb-25
- 03-Mar-25
- 03-Mar-25
- 0.01
- Announced on
- Record Date
- Ex-Bonus
- Description
- 29-Oct-24
- 26-Dec-24
- 26-Dec-24
- Bonus issue in the ratio of 1:2 of Re. 1/-.
- Ex-Splits
- Old FV
- New FV
- Description
- 05-Aug-24
- 10
- 1
- Stock split from Rs.10/- to Re. 1/-.
